Dobutamine Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Dobutamine Hydrochloride Injection (injection) from Hainan Poly Pharm. Co., Ltd. with status Current. The shortage was first posted on 11/06/2017.
Shortage Details
- Status
- Current
- Company
- Hainan Poly Pharm. Co., Ltd.
- Package NDC
- 70436-203-80
- Dosage Form
- Injection
- Presentation
- Dobutamine Hydrochloride, Injection, 250 mg/20 mL (NDC 70436-203-80)
- Initial Posting
- 11/06/2017
- Revised Date